Isoliquiritigenin Inhibits Atherosclerosis by Blocking TRPC5 Channel Expression

• Main Authors: Jie Qi (Author), Jianguo Cui (Author), Baobin Mi (Author), Xiaohong Yan (Author), Wenwen Xu (Author), Hui Ma (Author), Qingtan Zhang (Author), Fang Xu (Author)
• Format: Book
• Published: Hindawi-Wiley, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Isoliquiritigenin (ISL) is a flavonoid isolated mainly from the licorice plant, a traditional Chinese herb. ISL has shown anticancer, anti-inflammatory, antioxidant, and antidiabetic activities. However, the pharmaceutical effects of ISL on atherosclerosis are seldom explored. In this study, we used...